Carcinogenesis, Teratogenesis & Mutagenesis ›› 2016, Vol. 28 ›› Issue (2): 103-106.doi: 10.3969/j.issn.1004-616x.2016.02.004

Previous Articles     Next Articles

Effect of vinorelbine tartrate lipid microsphere injection on growth of human breast cancer cells in nude mice

QI Xuesong, LI Ning, WANG Chunyan, TONG Peng, GOU Qiao, ZHENG Hui   

  1. Key Laboratory of Radiological Protection and Nuclear Emergency, National Institute for Radiological Protection, China CDC, Beijing 100088, China
  • Received:2015-11-02 Revised:2015-11-26 Online:2016-03-31 Published:2016-03-31

Abstract: OBJECTIVE: To study the effect of vinorelbine tartrate lipid microsphere (NVB-lip) injection on growth of human breast cancer cells in nude mice. METHODS: 35 female BALB/c-nu mice were inoculated with human breast cancer BCAP-37 cells. These mice were divided randomly into 5 groups for further treatments:NVB-lip high dose group (NVB-lip 10 mg/kg), medium dose group (NVB-lip 5 mg/kg), low dose group (NVB-lip 2.5 mg/kg), positive drug control group (NVB-free 5 mg/kg) and negative control group (only lipid microsphere). There were 7 mice each group. Injection with NVB-lip was done after 6-8 days when the tumors shaped. NVB-lip was injected intravenously every 3 or 4 days each week for 6 times in total. Weights and tumor volumes(VT) of mice were observed and measured on No. 4, 7, 11, 14, 18 and 23 days from the first injection. Relative tumor volumn(VRT), relative tumor proliferation rate and tumor inhibition rate were calculated. RESULTS: The weights of nude mice for different groups increased slowly but the differences were not statistically significant. Compared with the negative group, the (VRT) and relative tumor proliferation rates of NVB-lip groups were reduced but tumor inhibition rate was increased. The differences were statistically significant (P<0.01). CONCLUSION: The inhibition of NVB-lip high dose group(2.5-10 mg/kg) was more obviously than that of the other groups. NVB-lip may have clinical applications.

Key words: vinorelbine tartrate lipid microsphere injection, nude mice, human breast cancer, tumor inhibition

CLC Number: